Then, we measured the anxiety-related behaviors and the symptoms of IBD after overexpression of IL-19 in colon; furthermore, we evaluated how IL-19 affects the sensitivity of the DSS/CUS-induced comorbid anxious behaviors; the pathological severities and their molecular pathways were determined. The gene discussed is IL19; the disease is Anxiety.